Abstract
Anamorsin is a cell-death-defying factor, which was originally isolated as a molecule that conferred resistance to apoptosis induced by growth factor starvation. In order to evaluate anamorsin expression levels in malignant lymphoma, we immunostained paraffin-embedded sections with anti-anamorsin monoclonal antibodies. About 40% (89/234) of sections from patients with diffuse large B cell lymphoma (DLBCL) showed strong anamorsin expression. Comparing the level of anamorsin expression in DLBCL patients with their clinical features (i.e., overall survival rate, International Prognostic Index (IPI) parameters, and treatment response) revealed no significant correlation between anamorsin expression levels and these clinical features. However, anamorsin expression in DLBCL patients with a low IPI was shown to be an unfavorable biomarker, especially in the patients who received chemotherapy without rituximab. It is suggested that anamorsin might play some roles in the abnormal growth of DLBCL.
References
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Jan 12, 2002·Nature Medicine·Margaret A ShippTodd R Golub
Feb 7, 2002·Blood·Sharon L BarransAndrew S Jack
Mar 1, 2002·The New England Journal of Medicine·David G Savage, Karen H Antman
Jul 13, 2002·Cancer·Richard B WilderJames D Cox
Sep 25, 2003·Blood·Christine P HansWing C Chan
Oct 1, 2003·Pathology International·Yutaka HatanakaYoichi Tani
Feb 19, 2004·The Journal of Experimental Medicine·Hirohiko ShibayamaYuzuru Kanakura
Jun 5, 2004·Acta Haematologica·Daniela Cilloni, Giuseppe Saglio
Aug 18, 2004·Current Opinion in Oncology·Randy D Gascoyne
Nov 9, 2004·Nature Medicine·Jose M PoloAri Melnick
Feb 22, 2005·Histopathology·I BiasoliN Spector
Mar 24, 2005·Blood Reviews·Asher Chanan-Khan
Jul 15, 2005·The New England Journal of Medicine·Daniela S Krause, Richard A Van Etten
Dec 13, 2005·Cancer·Grace Wu, Armand Keating
Jan 18, 2006·Cancer Biology & Therapy·Zhiming HaoDaiming Fan
Jan 19, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Javeed IqbalWing C Chan
Jan 19, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Izidore S Lossos, Daniel Morgensztern
Feb 2, 2006·Blood·Jane N WinterRandy D Gascoyne
Mar 1, 2006·Molecular Cancer Therapeutics·Yu-Chin LienDaret K St Clair
Jun 27, 2006·Clinical Lymphoma & Myeloma·Latha Shivakumar, James O Armitage
Aug 24, 2006·Expert Review of Anticancer Therapy·Gerhard HeldMichael Pfreundschuh
Oct 10, 2006·Seminars in Hematology·Owen A O'Connor, Paul Hamlin
Oct 14, 2006·Leukemia·P De Paepe, C De Wolf-Peeters
Citations
Aug 31, 2011·Medical Oncology·Liang WangYue Lu
Jun 9, 2012·Cancer Gene Therapy·X ChenX Ouyang
Jan 21, 2014·Experimental Hematology·Akira TanimuraYuzuru Kanakura
Jun 21, 2012·World Journal of Surgical Oncology·Xiaolan CaiXiaoyan Xin
Aug 6, 2011·Leukemia & Lymphoma·Liang WangYue Lv
Apr 7, 2010·Expert Opinion on Therapeutic Targets·Xiaohua LiDaiming Fan
Apr 26, 2011·Biochemical and Biophysical Research Communications·Yuri SaitoYuzuru Kanakura
Jan 12, 2011·Biochemical and Biophysical Research Communications·Yuri SaitoYuzuru Kanakura
Dec 19, 2015·Biochemical Pharmacology·Jian WangTianxiang Pang
Apr 29, 2015·Developmental and Comparative Immunology·Don Anushka Sandaruwan ElvitigalaJehee Lee
Jun 22, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Dan LuXuemei Wang
May 17, 2019·Oxidative Medicine and Cellular Longevity·Jian WangLili Yang